Exclusion Criteria:~1. With large-artery stroke (thrombotic stroke)~2. With radiological evidence of other
brain disorders (subdural hematoma, post-traumatic / post-surgery)~3. With dementia caused by other brain
diseases except Alzheimer's disease and vascular dementia (e.g. Parkinson's disease, demyelinated disease of
the central nervous system, tumor, hydrocephalus, head injury, central nervous system infection including
syphilis, acquired immune deficiency syndrome, etc.)~4. With clinical evidence of pulmonary, hepatic,
gastrointestinal, metabolic, endocrine or other life threatening diseases judged by investigators not suitable
to enter the study~5. With clinically unstable hypertension, diabetes mellitus, and cardiac disease for the
last 3 months~6. With history of stroke and hospitalized for stroke in the previous 3 months~7. With history of
alcohol or drug abuse~8. With one of the following abnormal laboratory parameters: hemoglobin < 10 mg/dL or
platelet < 100\*109/L; creatinine or total bilirubin more than 1.5 times the upper limit value; alanine
aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphates (ALP), or Î³-glutamyl transferase
(Î³-GT) more than 2 times the upper limit of normal~9. With depression, not well-controlled with
medications.~10. With any uncontrolled illness judged by the investigator that entering the trial may be
detrimental to the patient~11. With known or suspected hypersensitivity to any ingredients of study product and
vehicle~12. Pregnant or lactating or premenopausal with childbearing potential but not taking reliable
contraceptive method(s) during the study period~13. Enrollment in any investigational drug trial within 4 weeks
before entering this study
